Genetic Testing Services Market

Genetic Testing Services Market (Test Type: Prenatal Testing, New Born Screening, Predictive & Presymptomatic Testing, Pharmacogenomic Testing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Genetic Testing Services Market Outlook 2031

  • The global industry was valued at US$ 15.0 Bn in 2022
  • It is projected to expand at a CAGR of 8.4% from 2023 to 2031 and reach more than US$ 31.5 Bn by the end of 2031

Analysts’ Viewpoint

Increase in prevalence of genetic disorders and rise in awareness about personalized medicine is driving the genetic testing services market size. Advancements in technology, such as next-generation sequencing and gene editing techniques, have improved the accuracy, efficiency, and affordability of genetic testing, further fueling market expansion.

Increase in adoption of direct-to-consumer gene testing kits has made genetic testing more accessible to individuals. These kits allow consumers to obtain genetic information from the comfort of their homes, enabling personalized health management and ancestry exploration, thereby boosting the genetic testing services industry.

Market players are adopting partnership and collaboration strategies to increase revenue. They are also focusing of product portfolio expansion to broaden customer base.

Genetic Testing Services Market

Global Genetic Testing Services Market Introduction

Genetic testing services refer to the analysis of an individual's genetic material, such as DNA testing, to identify genetic disorders, predict disease risks, and guide personalized treatment plans. These services have gained significant importance in the field of healthcare due to their potential to provide valuable insights into an individual's genetic makeup and help making informed medical decisions.

DNA analysis services encompass a wide range of applications, including carrier testing, prenatal testing, diagnostic testing, predictive testing, and pharmacogenomic testing. Carrier testing helps identify individuals who carry a gene for a specific genetic disorder and may pass it on to their offspring.

Prenatal testing involves examining fetal DNA to detect genetic abnormalities or conditions before birth. Diagnostic testing is used to confirm or rule out a suspected genetic disorder based on symptoms or family history.

Rise in Prevalence of Genetic Disorders Propelling Genetic Testing Services Market Value

Increase in prevalence of genetic disorders across the globe is fueling the global genetic testing services market. Genetic testing plays a crucial role in diagnosing and managing these disorders, enabling early intervention and personalized treatment plans.

Genetic testing helps healthcare providers make informed decisions about patient care, leading to improved outcomes, by identifying specific genetic variations and mutations. Continuous rise in incidence of genetic diseases is expected to lead to the genetic testing services market growth, resulting in innovation in the field.

Surge in Demand for Personalized Medicine

Rise in demand for personalized medicine offers lucrative genetic testing services market opportunities to market players. Personalized medicine aims to customize healthcare based on an individual's unique genetic information. Genetic testing plays a critical role in this approach by providing insights into an individual's genetic makeup, disease risks, and treatment responses.

Healthcare providers can make more informed decisions about disease prevention, diagnosis, and treatment, by utilizing genetic testing results, leading to improved patient outcomes. Surge in adoption of personalized medicine practices is driving the genetic testing services market demand and shaping the future of healthcare.

Advancements in Genetic Testing Technologies in Emerging Economies

Technological advancements in genetic testing includes next-generation gene sequencing services, microarray analysis, and PCR. These advancements have significantly improved the accuracy, speed, and affordability of genetic testing. They have made genetic testing more accessible to healthcare providers and patients, driving market progress.

The enhanced capabilities of these technologies have facilitated high adoption of genetic testing services and expanded their applications in various healthcare settings, contributing to the genetic testing services market development.

High Demand for Prenatal Testing During Pregnancy

According to the latest genetic testing services market trends, the prenatal testing product segment is estimated to dominate the industry during the forecast period. Prenatal testing experiences high demand during pregnancy due to several factors.

Expectant parents seek prenatal testing to assess the health and development of the fetus, identify potential genetic disorders or chromosomal abnormalities, and make informed decisions about the pregnancy. This is expected to influence the genetic testing services market statistics.

Regional Outlook

According to the latest genetic testing services market forecast, North America is expected to hold the largest market share during 2022-2031. This can be ascribed to factors such as advanced healthcare infrastructure, increased adoption of genetic testing, favorable reimbursement policies, and high prevalence of genetic disorders in the region.

North America's strong market presence reflects its significant contribution in the growth and development of genetic testing services.

Asia Pacific is expected to register a substantial genetic testing services market CAGR during the forecast period. Large population base, increase in disposable income, rise in awareness about genetic disorders, and improvements in healthcare infrastructure contribute to the regional market expansion. Rise in healthcare expenditure and focus on personalized medicine in countries such as China, India, and Japan are also augmenting market statistics.

Advancements in technology and availability of cost-effective genetic testing solutions are propelling market demand in the region. Collaborations between international and local players are also fostering market development. Overall, these factors are likely to provide significant growth opportunities to the industry players during the forecast period.

Analysis of Key Players

Small number of dominant players hold substantial market share, indicating a consolidated industry. These companies prioritize research and development by making significant investments in this area.

Players in the market focus on expanding their product portfolios and adopting mergers and acquisitions strategies. This allows them to enhance their offerings and gain a competitive edge.

Companies profiled in the global genetic testing services market include Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Illumina, Inc., and 23andMe, Inc.

Key Market Developments

  • In March 2022, Illumina launched a cancer test in Europe that examines a broad range of tumor genes using a single tissue sample. This test offers potential benefits for patients with rare diseases, as it helps match them with suitable treatment options based on comprehensive genomic analysis.
  • In June 2022, Prenetics Group Limited introduced ColoClear by Circle, a non-invasive at-home screening test for early detection of colorectal cancer. This novel test enhances the ability to identify signs of colorectal cancer in its early stages, improving treatment outcomes.

Key players have been profiled in the genetic testing services market report based on parameters such as product portfolio, recent developments, financial overview, company overview, business strategies, and business segments.

Global Genetic Testing Services Market Snapshot

Attribute Detail

Size in 2022

US$ 15.0 Bn

Forecast (Value) in 2031

More than US$ 31.5 Bn

Growth Rate (CAGR)

8.4%

Forecast Period

2023-2031

Historical Data Available for

2017-2022

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Test Type
    • Prenatal Testing
    • New Born Screening
    • Predictive & Presymptomatic Testing
    • Pharmacogenomic Testing
    • Others
  • Service Provider
    • Hospital-based Laboratories
    • Diagnostic Laboratories
    • Specialty Clinics
    • Others
  • Application
    • Oncology
    • Infectious Diseases
    • Autoimmune Diseases
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Genomic Health, Inc.
  • NeoGenomics Laboratories, Inc.
  • Eurofins Scientific
  • Ambry Genetics
  • Illumina, Inc.
  • 23andMe, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global genetic testing services market in 2022?

The global industry was valued at US$ 15.0 Bn in 2022

How big is the global genetic testing services industry expected to be in 2031?

It is projected to reach more than US$ 31.5 Bn by 2031

What CAGR is the genetic testing services sector expected to register during the forecast period?

It is anticipated grow at a CAGR of 8.4% from 2023 to 2031

Which segment accounted for major share of the genetic testing services business?

The prenatal testing segment held the largest share in 2022

Which region is likely to be attractive for providers of genetic testing services?

North America is expected to be an attractive region

Who are the prominent players in the genetic testing services field?

Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Illumina, Inc., and 23andMe, Inc. are the prominent players in the market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Genetic Testing Services Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Genetic Testing Services Market Analysis and Forecast, 2017-2031

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Regulatory Scenario by Region/Globally

    5.2. Disease Prevalence & Incidence Rate Globally with Key Countries

    5.3. Technological Advancements

    5.4. COVID-19 Impact Analysis

6. Global Genetic Testing Services Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Test Type, 2017 - 2031

        6.3.1. Prenatal Testing

        6.3.2. New Born Screening

        6.3.3. Predictive & Presymptomatic Testing

        6.3.4. Pharmacogenomic Testing

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Test Type

7. Global Genetic Testing Services Market Analysis and Forecast, by Service Provider

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Service Provider, 2017-2031

        7.3.1. Hospital-based Laboratories

        7.3.2. Diagnostic Laboratories

        7.3.3. Specialty Clinics

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Service Provider

8. Global Genetic Testing Services Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Application, 2017-2031

        8.3.1. Oncology

        8.3.2. Infectious Diseases

        8.3.3. Autoimmune Diseases

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by Application

9. Global Genetic Testing Services Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Genetic Testing Services Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Test Type, 2017-2031

        10.2.1. Prenatal Testing

        10.2.2. New Born Screening

        10.2.3. Predictive & Presymptomatic Testing

        10.2.4. Pharmacogenomic Testing

        10.2.5. Others

    10.3. Market Value Forecast, by Service Provider, 2017-2031

        10.3.1. Hospital-based Laboratories

        10.3.2. Diagnostic Laboratories

        10.3.3. Specialty Clinics

        10.3.4. Others

    10.4. Market Value Forecast, by Application, 2017-2031

        10.4.1. Oncology

        10.4.2. Infectious Diseases

        10.4.3. Autoimmune Diseases

        10.4.4. Others

    10.5. Market Value Forecast, by Country, 2017-2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Test Type

        10.6.2. By Service Provider

        10.6.3. By Application

        10.6.4. By Country

11. Europe Genetic Testing Services Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Test Type, 2017-2031

        11.2.1. Prenatal Testing

        11.2.2. New Born Screening

        11.2.3. Predictive & Presymptomatic Testing

        11.2.4. Pharmacogenomic Testing

        11.2.5. Others

    11.3. Market Value Forecast, by Service Provider, 2017-2031

        11.3.1. Hospital-based Laboratories

        11.3.2. Diagnostic Laboratories

        11.3.3. Specialty Clinics

        11.3.4. Others

    11.4. Market Value Forecast, by Application, 2017-2031

        11.4.1. Oncology

        11.4.2. Infectious Diseases

        11.4.3. Autoimmune Diseases

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Test Type

        11.6.2. By Service Provider

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Genetic Testing Services Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Test Type, 2017-2031

        12.2.1. Prenatal Testing

        12.2.2. New Born Screening

        12.2.3. Predictive & Presymptomatic Testing

        12.2.4. Pharmacogenomic Testing

        12.2.5. Others

    12.3. Market Value Forecast, by Service Provider, 2017-2031

        12.3.1. Hospital-based Laboratories

        12.3.2. Diagnostic Laboratories

        12.3.3. Specialty Clinics

        12.3.4. Others

    12.4. Market Value Forecast, by Application, 2017-2031

        12.4.1. Oncology

        12.4.2. Infectious Diseases

        12.4.3. Autoimmune Diseases

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Test Type

        12.6.2. By Service Provider

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Genetic Testing Services Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Test Type, 2017-2031

        13.2.1. Prenatal Testing

        13.2.2. New Born Screening

        13.2.3. Predictive & Presymptomatic Testing

        13.2.4. Pharmacogenomic Testing

        13.2.5. Others

    13.3. Market Value Forecast, by Service Provider, 2017-2031

        13.3.1. Hospital-based Laboratories

        13.3.2. Diagnostic Laboratories

        13.3.3. Specialty Clinics

        13.3.4. Others

    13.4. Market Value Forecast, by Application, 2017-2031

        13.4.1. Oncology

        13.4.2. Infectious Diseases

        13.4.3. Autoimmune Diseases

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017-2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Test Type

        13.6.2. By Service Provider

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Genetic Testing Services Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Test Type, 2017-2031

        14.2.1. Prenatal Testing

        14.2.2. New Born Screening

        14.2.3. Predictive & Presymptomatic Testing

        14.2.4. Pharmacogenomic Testing

        14.2.5. Others

    14.3. Market Value Forecast, by Service Provider, 2017-2031

        14.3.1. Hospital-based Laboratories

        14.3.2. Diagnostic Laboratories

        14.3.3. Specialty Clinics

        14.3.4. Others

    14.4. Market Value Forecast, by Application, 2017-2031

        14.4.1. Oncology

        14.4.2. Infectious Diseases

        14.4.3. Autoimmune Diseases

        14.4.4. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Test Type

        14.6.2. By Service Provider

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2022

    15.3. Company Profiles

        15.3.1. Laboratory Corporation of America Holdings

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Service Provider Portfolio

            15.3.1.3. Financial Overview

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. Quest Diagnostics Incorporated

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Service Provider Portfolio

            15.3.2.3. Financial Overview

            15.3.2.4. SWOT Analysis

            15.3.2.5. Strategic Overview

        15.3.3. Genomic Health, Inc.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Service Provider Portfolio

            15.3.3.3. Financial Overview

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. NeoGenomics Laboratories, Inc.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Service Provider Portfolio

            15.3.4.3. Financial Overview

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. Eurofins Scientific

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Service Provider Portfolio

            15.3.5.3. Financial Overview

            15.3.5.4. SWOT Analysis

            15.3.5.5. Strategic Overview

        15.3.6. Ambry Genetics

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Service Provider Portfolio

            15.3.6.3. Financial Overview

            15.3.6.4. SWOT Analysis

            15.3.6.5. Strategic Overview

        15.3.7. Illumina, Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Service Provider Portfolio

            15.3.7.3. Financial Overview

            15.3.7.4. SWOT Analysis

            15.3.7.5. Strategic Overview

        15.3.8. 23andMe, Inc.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Service Provider Portfolio

            15.3.8.3. Financial Overview

            15.3.8.4. SWOT Analysis

            15.3.8.5. Strategic Overview

List of Tables

Table 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 02: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 03: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 04: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Region, 2017-2032

Table 05: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country, 2017-2032

Table 06: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 07: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 08: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 09: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 10: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 11: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 12: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 13: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 14: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 15: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 16: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 17: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 18: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 19: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 20: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 21: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 22: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 23: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 24: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

List of Figures

Figure 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032

Figure 02: Genetic Testing Services Market Value Share, by Test Type, 2022

Figure 03: Genetic Testing Services Market Value Share, by Service Provider, 2022

Figure 04: Genetic Testing Services Market Value Share, by Application, 2022

Figure 05: Global Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032

Figure 06: Global Genetic Testing Services Market Revenue (US$ Mn), by Prenatal Testing, 2017-2032

Figure 07: Global Genetic Testing Services Market Revenue (US$ Mn), by New Born Screening, 2017-2032

Figure 08: Global Genetic Testing Services Market Revenue (US$ Mn), by Predictive & Presymptomatic Testing, 2017-2032

Figure 09: Global Genetic Testing Services Market Revenue (US$ Mn), by Pharmacogenomic Testing, 2017-2032

Figure 10: Global Genetic Testing Services Market Revenue (US$ Mn), by Others, 2017-2032

Figure 11: Global Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032

Figure 12: Global Genetic Testing Services Market Revenue (US$ Mn), by Service Provider, 2017-2032

Figure 13: Global Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2017-2032

Figure 14: Global Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032

Figure 15: Global Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032

Figure 16: Global Genetic Testing Services Market Value Share Analysis, by Region, 2022 and 2032

Figure 17: Global Genetic Testing Services Market Attractiveness Analysis, by Region, 2023-2032

Figure 18: North America Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032

Figure 19: North America Genetic Testing Services Market Value Share Analysis, by Country, 2022 and 2032

Figure 20: North America Genetic Testing Services Market Attractiveness Analysis, by Country, 2023-2032

Figure 21: North America Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032

Figure 22: North America Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032

Figure 23: North America Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032

Figure 24: North America Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032

Figure 25: North America Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032

Figure 26: North America Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032

Figure 27: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032

Figure 28: Europe Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 29: Europe Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032

Figure 30: Europe Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032

Figure 31: Europe Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032

Figure 32: Europe Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032

Figure 33: Europe Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032

Figure 34: Europe Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032

Figure 35: Europe Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032

Figure 36: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032

Figure 37: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 38: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032

Figure 39: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032

Figure 40: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032

Figure 41: Asia Pacific Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032

Figure 42: Asia Pacific Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032

Figure 43: Latin America Genetic Testing Services Market Value Share Analysis, by Indication, 2022 and 2032

Figure 44: Latin America Genetic Testing Services Market Attractiveness Analysis, Indication, 2023-2032

Figure 45: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, 2017-2032

Figure 46: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 47: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023-2032

Figure 48: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Test Type, 2022 and 2032

Figure 49: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Test Type, 2023-2032

Figure 50: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Service Provider, 2022 and 2032

Figure 51: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Service Provider, 2023-2032

Figure 52: Middle East & Africa Genetic Testing Services Market Value Share Analysis, by Application, 2022 and 2032

Figure 53: Middle East & Africa Genetic Testing Services Market Attractiveness Analysis, by Application, 2023-2032

Copyright © Transparency Market Research, Inc. All Rights reserved